STATs in cancer inflammation and immunity: a leading role for STAT3
about
Differential pro-inflammatory responses of astrocytes and microglia involve STAT3 activation in response to 1800 MHz radiofrequency fieldsPreclinical evidences toward the use of triterpenoid CDDO-Me for solid cancer prevention and treatmentOxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's diseaseHER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesisJakinibs: a new class of kinase inhibitors in cancer and autoimmune diseaseCentral role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonistBLT2 is a pro-tumorigenic mediator during cancer progression and a therapeutic target for anti-cancer drug developmentPtpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesisProducer T cells: Using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumorsEmerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinomaThe emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applicationsThe SphKs/S1P/S1PR1 axis in immunity and cancer: more ore to be minedMyeloid-Derived Suppressor Cells in Bacterial InfectionsTargeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular diseaseCancer Stem Cell Hierarchy in Glioblastoma MultiformeRegulation of Natural Killer Cell Function by STAT3Epigenetic modulators, modifiers and mediators in cancer aetiology and progressionTumour progression and metastasisMicroRNAs in colorectal carcinoma--from pathogenesis to therapyNovel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic)Diagnostic and Prognostic Value of Serum Interleukin-6 in Colorectal CancerBiomarkers of cancer angioprevention for clinical studiesEmerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancerThe Role of the Transcriptional Regulation of Stromal Cells in Chronic Inflammation"TRP inflammation" relationship in cardiovascular systemTargeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor ImmunityRoles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic PathologiesImmunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesThe Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor BedsPancreatic cancer: optimizing treatment options, new, and emerging targeted therapiesThe Complex Role of STAT3 in Viral InfectionsTargeting the tumor microenvironment: JAK-STAT3 signalingThe role of obesity in gastrointestinal cancer: evidence and opinionNF-κB and STAT3 in glioblastoma: therapeutic targets coming of ageSphingosine-1-phosphate in chronic intestinal inflammation and cancerChemotherapy-enhanced inflammation may lead to the failure of therapy and metastasisTargeting JAK2 in the therapy of myeloproliferative neoplasmsOncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cellsTumor-infiltrating dendritic cells in cancer pathogenesisThe consequences of selective inhibition of signal transducer and activator of transcription 3 (STAT3) tyrosine705 phosphorylation by phosphopeptide mimetic prodrugs targeting the Src homology 2 (SH2) domain
P2860
Q21131937-DC4BE998-0006-4806-A7AD-78C56314B192Q21245749-50D19950-7ADD-4B21-90FE-326FC64DE067Q24337079-1CB6B9EA-FD5A-4B15-BEE8-531E9DFEFD18Q24598092-A6C684A3-A68B-4048-8177-F615BAD48D89Q24617270-85813A32-CE39-433A-A754-BC7DBA5C54A5Q24623979-C5404144-45B2-457F-B87D-60AE7BF52848Q24631264-C31F083B-D6B6-49F8-91A4-F8C29A3BEC6FQ24632905-156F6C7D-44D0-4E45-88A2-57E85048C865Q26741260-F752CDD8-DC8E-4CFA-A72F-C879F905D8E7Q26744051-1673D444-A189-4626-8C64-AF11A4E386C5Q26747516-B6FC6BB2-3164-4091-82B8-4B05BAD134D2Q26748848-1708E33B-3A57-4D4D-8B00-3B121A89C4C7Q26749373-CCA16FE9-2C0D-4C4E-99C7-55EC42DCD3ECQ26750725-E7A9955D-4F4E-499C-BE08-111A0D410FA3Q26752312-DE957596-1711-45B4-AE2A-614C4350C3DEQ26752551-F89BE135-D8F9-4963-8D66-29350B298C98Q26766149-E2B2CE3B-0A06-4736-90D6-C657EA754FC7Q26766468-093A60E3-815E-4595-9F29-198C4393D376Q26766510-40A01157-98F8-452B-949F-4B626D95B56EQ26770391-1A10A831-04CE-4609-B8D8-2DF3C91191F4Q26772049-AD62AC85-29E4-4E77-9F36-B61B5D98A3CEQ26774580-B3C8DFCA-57ED-4215-B602-1D3EBAF829F5Q26778509-638AF874-0B58-4F13-B9B4-621A7A19D6E3Q26778930-18B531ED-378F-4A42-BC78-AF5600D63BD0Q26781720-FE8A4996-3B4B-4E47-95FE-A271245A532BQ26782201-5BDD6353-2AFF-4078-8755-CBEA40C55B13Q26782979-2701BF3E-E6F9-4B6E-AED2-68BAD1EC8A90Q26798402-839FF017-F862-489E-877B-B3E3F60A072CQ26799120-E6D073BD-F465-4512-A9D8-362E7B8ECF97Q26799714-B16B7C6B-EE67-4081-89CD-B4C6919459B7Q26801053-E6955CD6-ECD9-4035-9C88-C82A8869B906Q26825658-0060760C-04BF-4D9E-9BC8-87654E21F601Q26825678-69845D71-B838-41B2-BDBE-50B66349A2AAQ26830388-2DAB6FF9-E383-4BA0-8D94-1802937236EDQ26852824-97376E99-CB85-43EA-8377-2DC17F02007BQ26858839-1C2A3E0A-D01F-47FC-AA16-729F8BECBF5EQ26860796-B4E1F6F8-F545-40D2-9EA9-65D6F0E63911Q26861403-30F9E2CF-C6D9-4E8A-8DA1-13EEA964407CQ26861633-784B225E-60D0-4568-97B7-76279BEF0611Q26861758-9F3424A3-0D1D-41BE-B15B-02C757FAB6E1
P2860
STATs in cancer inflammation and immunity: a leading role for STAT3
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
STATs in cancer inflammation and immunity: a leading role for STAT3
@ast
STATs in cancer inflammation and immunity: a leading role for STAT3
@en
type
label
STATs in cancer inflammation and immunity: a leading role for STAT3
@ast
STATs in cancer inflammation and immunity: a leading role for STAT3
@en
prefLabel
STATs in cancer inflammation and immunity: a leading role for STAT3
@ast
STATs in cancer inflammation and immunity: a leading role for STAT3
@en
P2093
P2860
P3181
P356
P1476
STATs in cancer inflammation and immunity: a leading role for STAT3
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/NRC2734
P407
P577
2009-11-01T00:00:00Z
P5875
P6179
1022123078